Ayr Wellness Inc.
AYRWF evidence brief
What we can confirm
What it means
What to watch
Prepared research question
What matters most for AYRWF—catalysts, financial risk and supporting evidence?
Traceable citations · Unknowns marked
BioSniper AI · AYRWF
Ayr Wellness Inc. is a cannabis company focused on cultivating, manufacturing, and distributing cannabis products across the U.S., with reported revenues of $463.6M and a net loss of $359.3M for the fiscal year ending December 31, 2024.
BioSniper Score
Based on 2 of 6 signals
Limited data coverage
Market Cap
$432K
Cash Runway
—
Lead Asset
—
Next Catalyst
—
Financial data as of Dec 31, 2024.
Tracking 5 clinical trials for Ayr Wellness Inc..
Ayr Wellness Inc. is a cannabis company focused on cultivating, manufacturing, and distributing cannabis products across the U.S., with reported revenues of $463.6M and a net loss of $359.3M for the fiscal year ending December 31, 2024.
- Total revenue of $463.6M for the fiscal year ending December 31, 2024 [sec].
- Net loss of $359.3M for the fiscal year ending December 31, 2024 [sec].
- Cash and equivalents of $35.5M as of December 31, 2024 [sec].
- Shareholders' equity of $379.5M and total debt of $435.3M as of December 31, 2024 [sec].
Sources: Competitor trials · Generated August 21, 2026 · How we verify sources →
Run Ayr Wellness Inc. through your own thesis
Use the pipeline, catalyst, financial, FDA, and market facts on this page as inputs to a protocol you control.
Your protocol can:
- Turn available Ayr Wellness Inc. facts into screen rules or deeper checks
- Show cited findings, blockers, and unresolved evidence together
- Save the logic and rerun it as the company evidence changes
Evidence & data
Score breakdownBased on 2 of 6 signals · derived from public data
No clinical pipeline tracked — this score reflects financial & catalyst signals only.
Profitable (positive operating cash flow)
D/E 2.38
No tracked pipeline phase
No tracked pipeline candidates
No upcoming catalysts tracked
No insider transactions in the last 180 days
Regulatory
Financials
Institutional Holdings
Source: SEC Form 13F · as of Mar 2026Institutional holders
3
Total value held
$8K
| Holder | Shares | Value |
|---|---|---|
| first national trust co | 510,991 | $8K |
| albert d mason inc | 12,946 | $203 |
| vsm wealth advisory, llc | 1 | $0 |
Frequently asked questions
What is the AI investment thesis for Ayr Wellness Inc.?
Ayr Wellness Inc. is a cannabis company focused on cultivating, manufacturing, and distributing cannabis products across the U.S., with reported revenues of $463.6M and a net loss of $359.3M for the fiscal year ending December 31, 2024.
Who is the CEO of Ayr Wellness Inc.?
Mr. Scott J. Davido is the chief executive officer of Ayr Wellness Inc. (AYRWF).
Where is Ayr Wellness Inc. headquartered?
Ayr Wellness Inc. (AYRWF) is headquartered in Miami, FL, United States.
The AI overview and BioSniper Score are neutral, data-derived signals built from public SEC filings, ClinicalTrials.gov and FDA records — not investment advice.